References
- Botton E, Saraux A, Laselve H, Jousse S, Le Goff P. Musculoskeletal manifestations in cystic fibrosis. Joint Bone Spine 2003;70:327–35.
- Gibson DJ, Gallagher CG, Doherty GA. Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn’s disease in a patient with pan resistant pseudomonas cystic fibrosis: a case report. J Crohns Colitis 2014;8:1561–2.
- Vincenzi F, Bizzarri B, Ghiselli A, De’ Angelis N, Fornaroli F, De’ Angelis GL. Cystic fibrosis and Crohn’s disease: successful treatment and long term remission with infliximab. World J Gastroenterol 2010;16:1924–7.
- Casserly B, Donat W. Stabilization of lung function and clinical symptoms in a patient with cystic fibrosis (CF) after institution of infliximab: a monoclonal antibody that binds tumor necrosis factor alpha. Lung 2009;187:149–52.
- Visser S, Martin M, Serisier DJ. Improvements in cystic fibrosis lung disease and airway inflammation associated with etanercept therapy for rheumatoid arthritis: a case report. Lung 2012;190:579–81.